CannaBiz Invest Asia,

29-30 Aug, 2019 - Bangkok, THAILAND

Holiday Inn Bangkok Sukhumvit

  • Coffee Break Reception Sponsor
    www.cmtevents.com/eventsponsorship.aspx?ev=190819&
  • Exhibitor
    Blue Sky Biologicals
  • Exhibitor
    Clearwater Bangkok
  • Promotion Partner
    Weed World
  • Promotion Partner
    phyllo.ai/cannabis/
  • Promotion Partner
    www.wholeplantextract.co.uk/contact/
  • Promotion Partner
    www.420group.co.uk
  • Promotion Partner
    www.biospectrumasia.com/
  • Promotion Partner
    infuzes.com/
  • Promotion Partner
    www.medicinal.news/category

29 Aug, 2019 - Thursday

08:00

Morning Registrations & Coffee

08:50

Chairman’s Welcome & Introduction

Mr. Warren Everitt, Managing Director

MediPharm Labs Australia PTY

09:00

Official Opening Address

09:15

INTEGRATION OF MEDICAL CANNABIS IN THAI TRADITIONAL MEDICINE - A BALANCING GAME

  • Research updates and plans moving forward
  • Raw materials sourcing & cultivation plans
  • Future patient access criteria

Dr. Khwanchai Visithanon, Director

(DTTAM) - Dept of Thai Traditional and Alternative Medicine, Ministry of Public Health

09:40

UNDERSTANDING THE MEDICAL CANNABIS INVESTMENT LANDSCAPE & REGULATORY HURDLES IN THAILAND

  • Who can invest and the value chain for participation
  • What licenses and permits are required and which authorities to seek approval?
  • Dissecting the regulations from imports of seeds/strains to cultivation, extraction & refining to distribution, orphan drugs & etc
  • Intellectual Property consideration for cannabis investment in Thailand

Dr. Atthachai Homhuan, Manager, Regulatory Affairs

Tilleke & Gibbins International Ltd

10:10

CHINA – INDUSTRIAL HEMP CULTIVATION & VALUE CHAIN INVESTMENT CASE STUDY

  • Access to seeds varieties &  cultivation investment challenges
  • CBD Oil extraction and value addition
  • Traceability and Compliance in the Cannabis Industry: Preparing for International Import and Export
  • Growth potential in China

Mr. Glenn Davies, Co-Founder & Group CEO

CannAcubed Pte Ltd

10:40

Networking Refreshment

11:10

GLOBAL CANNABIS MARKET OUTLOOK & INVESTMENT LANDSCAPE

  • Unlocking the cannabis market potential & challenges facing investors 

Cam Battley, Chief Corporate Officer

Aurora Cannabis Inc.

11:40

FROM FARM TO PHARMA – ISRAEL’S EXPERIENCE

  • Israel cannabis clinical trials and how it works in the Israel medical industry
  • Israel Medical cannabis Market compare to the EU Market

Mr. Golan Bitton, CEO & Co-Founder

Univo Pharmaceuticals Ltd

12:10

GROWTH OUTLOOK FOR HEMP FOODS, PROTEIN & THE CBD MARKET IN JAPAN & GLOBALLY

12:40

Networking Lunch

13:45

Afternoon Chairman’s Introduction

13:50

ACCESSING CAPITAL MARKETS FOR CANNABIS INVESTMENTS – OPTIONS & CHALLENGES

Panelists:  

Mr. Erick Factor, Executive Chairman & Founder

MYM International Brands Inc.

Mr. James Foster, Director

Canrim Growth Group

Anthony Dutton, CEO

Cannex Capital

14:20

CANNABIS LEGISLATION IN NEW ZEALAND: REFLECTIONS ON GOVERNMENT EFFORTS TO DESIGN WORLD-LEADING MEDICINAL CANNABIS & FULL LEGALISATION

  • Recent developments in New Zealand include the passing of Medicinal Cannabis legislation in 2018 and the current drafting of legislation for full legalisation that will be the subject of a national referendum in 2020. New Zealand is an advanced economy with a small population and strong democracy. Starting after other jurisdictions, the country has been able to take the best of existing examples around the globe to design world-leading legislation and regulations for the legal production and use of cannabis.

Mr. Manu Caddie, CEO

Hikurangi Cannabis Company

14:50

OUTLOOK OF THE MEDICAL CANNABIS INDUSTRY IN AUSTRALIA

  • Australian Cannabis Laws at a Glance
  • Medical cannabis research, production & clinical trials update
  • Economics of production for local and export markets
  • Medical professional’s attitude towards medical cannabis, prescription and patient access challenges

Mr. Fabian Szatmary, Vice President and Territory Manager (Asia Pacific)

MYM Nutraceuticals Inc

15:20

Networking Refreshment

15:50

HEMP: BEYOND CBD & THC, A WHOLE PLANT MODEL

  • A plant that we have had a 5000+ year history with it gaining worldwide acceptance once again and the entire benefits of this plant are still mostly unknown. The hemp plant delivers tremendous benefits in the areas of Food, Fibre and Medicine and we will explore all of these areas with a focus on the medicine, which we have only begun to truly understand.

Preet Marwaha, CEO

Blue Sky Biologicals

16:20

THE FUTURE OF SUSTAINABLE FASHION & HEMP FIBRES INDUSTRY

Mr. Andy Chan, CFO

Kingdom Holdings Limited

16:50

CBD – THE NEXT BIG THING IN BEAUTY?

  • Emerging trends & market size for CBD infused beauty & personal care products
  • How regulation will affect the CBD beauty industry & supply chain?
  • Formulation & standards
  • Marketing & distribution channels

Dr. Adele Hosseini, Chief Scientific Officer

Bod Australia Ltd

17:20

End of Day One

17:30

Networking Refreshment for all Speakers & Participants

30 Aug, 2019 - Friday

09:00

Chairman’s Introduction

09:10

INDUSTRIAL AND MEDICAL CANNABIS INVESTMENT IN INDIA – SCIENTIFIC AND LEGAL PERSPECTIVE

  • Cannabis – India’s next Green revolution & what the future holds?
  • BOHECO’s scientific, policy & commercial endeavours to bring Hemp into the mainstream in India
  • Innovations with Industrial Hemp & Medicinal Cannabis – What’s in store from an India & Asia horizon
  • Navigating legal landscape moving forward

Mr. Jahan Peston Jamas, Co-founder & & Director, Strategic Development and Collaborations

Bombay Hemp Company Private Limited (BOHECO)

09:40

“GREEN GREEN PROFITS” - THE CULTIVATION OF OUTDOOR MEDICAL CANNABIS AS A BUSINESS MODEL FOR ASIA

  • Cultivation Methods and Facility Design - Outdoor vs. Indoor, Advantages and Disadvantages
  • Sustainability - Why it should be an integral part of your business model
  • Quality Assurance - How outdoor grown medical cannabis can meet and exceed international quality standards

Mr. Markus Hoffmann, VP of Business Development

Jacana Holdings Inc.

10:10

AUSTRALIA’S ROLE IN APAC MEDICAL CANNABIS MARKET

  • Australia’s first mover advantage
  • Pharmaceutical Gold Standard
  • Global Supply Chain
  • ANZ Product Premiums

Mr. Pat McCutcheon, CEO

MediPharm Labs Corp.

Mr. Warren Everitt, Managing Director

MediPharm Labs Australia PTY

10:40

Networking Refreshment

hosted by

https://www.cmtevents.com/EVENTDATAS/190819/sponsors/MediPharm200px.jpg

11:10

SPECTRUM OF GENETICS

  • Cannabis seeds & strains selection
  • Effect of strains on crop Yield and cannabinoid content
  • Plant variety protection

Mr. Srinivasa Reddy, COO

Leaf Cross Biomedical Inc.

11:40

COMMERCIALIZATION OF PLANT-DERIVED CANNABINOID PRESCRIPTION MEDICINES TO MEET GLOBAL DEMAND

  • Plans beyond CannEpil
  • Ensuring supply & ensuring consistency in plant-based raw materials for commercial production
  • Clearing regulatory approvals for global distribution

Mr. Blaise Bratter, Australia Operations Manager

MGC Pharmaceuticals Ltd

12:10

PHARMACEUTICAL DEVELOPMENT IN MAN-MADE CANNABINOIDS

  • Genetic engineering and the prospect of man-made cannabinoids
  • Is it a more economical & regulatory-friendly alternative to natural CBD?

Mr. Manit Patel, Chief Executive Officer

Akseera Pharma Corp

12:40

Final Discussion followed by Closing Lunch

DISCLAIMER

It may be necessary for reasons beyond CMT's control to alter the content, timings, dates or venue of an event. CMT will not accept liability for any kind of disruptions or any claims whatsoever and in such circumstances CMT's normal cancellation terms apply.